Dedicated multifunctional test platform for clinical examination of cell bone marrow

Abstract

The invention belongs to the technical field of clinical examination of cells, and discloses a dedicated multifunctional test platform for clinical examination of cell bone marrow. The platform comprises: a cell image acquisition module, a main control module, a cell labeling module, a cell analysis module, a test evaluation module, a retrieval module, a network communication module, and a displaymodule. The platform marks the classification information of the cells by the cell labeling module while marking the cell name information; and realizes that each type of cells has a specific and non-repeating color mark, which is not only easy to read but also avoids naming conflicts, and is also convenient to check. Meanwhile, the change condition of the quality of the clinical trial can be clearly understood through the test evaluation module after the checking, so as to adjust the subsequent clinical trials.

Description

technical field [0001] The invention belongs to the field of clinical cell technology, and in particular relates to a multifunctional test platform for clinical cell bone marrow specialty. Background technique [0002] Bone marrow examination is one of the most popular and effective diagnostic examination methods commonly used in clinic. Bone marrow examination can be used in the diagnosis of hematopoietic system diseases, such as the differential diagnosis of leukemia, the differential diagnosis of various anemias, the diagnosis of multiple myeloma and the increase or decrease of platelets. Due to physiological variation and different survey data, the cell ratio of each system and stage of normal bone marrow picture varies widely, so the actual meaning of normal bone marrow picture is the normal range of bone marrow picture, and the decreased data can be used as the normal value of various blood cells in bone marrow smear Reference: The granulocyte system accounts for the ...

AI Technical Summary

Problems solved by technology

[0004] When labeling existing bone marrow cells, using cell names to label cells is not easy to read; and different experts, hospitals, regions, and countries will define different cell names for certain types of cells, and only using cell names to label cells will easily cause understand the conflict;

[0005] At the same time, in the process of clinical cell bone marrow test, it is difficult to achieve objective standard evaluation by relying on manual traditional mode, so it is impossible to establish a standardized evaluation system, so as to realize the dynamic tracking of clinical trial quality and the improvement of clinical trials after inspection

[0006] In the prior art, the image data of bone marrow cells collected by medical imaging equipment is relatively blurred and the definition is poor, which is not conducive to the observation and judgment of the image data; The edge of the image is lost; in the prior art, the data has been disturbed by the outside during the transmission of the bone marrow cell test data, resulting in data loss and errors, reducing the accuracy of the data output

Images